Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT05275205Phase 2Completed
Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)
Neovascular Age-related Macular Degeneration
StudydirectorStart date: 2022-03-02

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Unity Biotechnology, Inc.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xiaorong Li, professor

Tianjin Medical University Eye Hospital

Related
5 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

Jamie Dananberg, MD

UNITY Biotechnology

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration

Worked with same sponsors:

Unity Biotechnology, Inc.
Similarity Score15%

Se Joon Woo

Seoul National University Bundang Hospital, South Korea

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

Mingwei Zhao, PhD

Peking University People's Hospital

Related
3 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

Federico Grossi, MD PhD

Apellis Pharmaceuticals, Inc.

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

Sotaro Takigawa

Kyowa Kirin Co., Ltd.

Related
2 trials

Shared therapeutic areas:

Diabetic Macular Edema (DME)
Similarity Score15%

Jeffrey Heier, MD

Ophthalmic Consultants of Boston

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

Diana V Do, MD

Johns Hopkins University

Related
2 trials

Shared therapeutic areas:

Diabetic Macular Edema (DME)
Similarity Score15%

Katja Hatz, MD

Vista Klinik Binningen

Related
3 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

Hanyi Min

Peking Union Medical College Hospital

Related
1 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05275205Phase 2StudyDirector

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

Neovascular Age-related Macular Degeneration
Completed
NCT04857996Phase 2StudyDirector

Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD)

Diabetic Macular Edema (DME)
Completed

All 2 trials loaded